Previous Page  5 / 6 Next Page
Information
Show Menu
Previous Page 5 / 6 Next Page
Page Background

Volume 3

Diagnostic Pathology: Open Access

ISSN: 2476-2024

Laboratory Medicine 2018

June 25-26, 2018

Page 50

conference

series

.com

June 25-26, 2018 | Berlin, Germany

13

th

International Conference on

Laboratory Medicine & Pathology

Ian James Martins, Diagn Pathol Open 2018, Volume 3

DOI: 10.4172/2476-2024-C1-001

The Limitations Of Laboratory Medicine With Relevance To Biomarker Tests And Global Organ

Disease

V

arious diagnostic technologies have been used with relevance to genomics, lipidomics and proteomics to allowmore sensitive

interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome,

proteome and metabolome (central dogma of biology) and determine the cell genome (nuclear receptors) and transcription factor

alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis

is expected to be approximately 52 billion dollars by the year 2020. Major efforts with biomarkers have been identified with plasma

protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements

for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions

involved in mitochondrial apoptosis and the induction of programmed cell death.

Biography

Dr. Ian Martins is a Reveiwer for international journals. Chief Editor for International Journal of Diabetes Research (2014-2017), Research and Reviews: Neuroscience

(2016-2017), Journal of Diabetes and Clinical Studies. BIT Member (BIT Congress. Inc) with

H-index

of 43, (ResearchGate STATs (23), Mendeley STATS (20). Scientist

for Science Advisory Board (USA)/Academic with

Academia.edu.

Citations > 3000. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian

James Martins’ name > 96% of the international SCIENTISTS. Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical

Science (Nutrition). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGYAND METABOLISM.

i.martins@ecu.edu.au

Ian James Martins

Edith Cowan University, Australia